From: Using the best available data to estimate the cost of antimicrobial resistance: a systematic review
 | Parameters for assessment |
---|---|
Study perspective | What is the study perspective? The study perspective (s) is the viewpoint from which the intervention’s costs and consequences are evaluated [42]. |
Patient perspective Example: out-of-pocket costs or patient preference, costs that the patient pays for that are not covered by their health insurance | |
Healthcare payer perspective Example: attributable costs to the payers of healthcare including insurers or national payers | |
Healthcare system perspective Example: cost effectiveness analysis of stewardship programs, additional length of hospital stay, impact of resistant infections on structuring of cares such as infection control, increased use of isolation rooms | |
Societal perspective Example: broader costs to society such as productivity loss due to morbidity or premature death, can include cost to other sectors such as impact on trade and economy | |
Methodology | Did the study match the resistant cases and susceptible control groups based on LOS prior to infection? or |
Did the study adjust statistically for prior LOS? or | |
Did the study conduct sensitivity analysis that considered hospital LOS prior to infection? or | |
Was multistate modelling used to take into account the time-varying nature of infections? | |
 If yes, low to moderate risk of time dependent bias | |
 If no, high risk | |
 If unsure, check: Did the study estimate excess LOS, mortality or costs without matching by LOS prior to infection | |
Did the study express only post-infection LOS or costs? | |
 If yes to any of the above then high risk of time-dependent bias | |
Did the study adjust for underlying co-morbidities or severity of illness on clinical outcomes | |
 If yes, did they adjust for time-dependent bias (above)? | |
 If no, high-risk of bias | |
Did the study adjust for inappropriate antibiotic therapy | |
 If yes, did they adjust for time-dependent bias (above)? | |
 If no, high-risk of bias | |
Minimum study characteristics to be reported | Country |
Year of data used for analysis | |
Organism, susceptibility, and site of infection | |
Comparator | |
Study design and analysis methods | |
Cost driver/ costs explored (e.g., excess LOS, mortality) | |
Type of costs (including year of cost data and currency) | |
Statistical significance |